Skip to content

Integra LifeSciences IART Contract Liabilities

Contract Liabilities at other companies

ITG
Integer HoldingsITGR
$3.03M-15.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$1.37M-7.0%
CONMED logo
CONMEDCNMD
$23.41M+16.7%
ICU Medical logo
ICU MedicalICUI
$67.5M+61.9%
Globus Medical logo
Globus MedicalGMED
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's contract liabilities?
Integra LifeSciences (IART) reported contract liabilities of $10.8M in Q1 2026.
How has Integra LifeSciences's contract liabilities changed year-over-year?
Integra LifeSciences's contract liabilities increased by 14.9% year-over-year, from $9.4M to $10.8M.
What does contract liabilities mean?
Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.